ARTICLE | Clinical News
MEI gains on preliminary AML data for pracinostat
June 11, 2014 12:25 AM UTC
MEI Pharma Inc. (NASDAQ:MEIP) gained $0.89 (15%) to $7.03 on Tuesday after reporting that oral pracinostat (formerly SB939) met the pre-specified criteria to advance to the second stage of an open-lab...